Premium
More than medication: The importance of family treatments for pediatric bipolar disorder
Author(s) -
MacPherson Heather A.
Publication year - 2020
Publication title -
the brown university child and adolescent behavior letter
Language(s) - English
Resource type - Journals
eISSN - 1556-7575
pISSN - 1058-1073
DOI - 10.1002/cbl.30433
Subject(s) - irritability , bipolar disorder , mood , psychosocial , psychology , euphoriant , depression (economics) , psychiatry , stressor , clinical psychology , cognition , economics , macroeconomics
Pediatric bipolar disorder (PBD) is a chronic and debilitating illness characterized by episodic mood disturbance (e.g., extreme irritability, euphoria, and/or depression), accompanying symptoms (e.g., energy shifts, sleep disruption, cognitive disturbance of self/abilities, suicidality), high rates of comorbidities, and considerable functional impairment. Although PBD has biological underpinnings, cognitive, behavioral, and environmental stressors can trigger or exacerbate depressive and manic symptoms. Thus, while pharmacotherapy is effective for controlling biological contributions to mood episodes, psychotherapy is also necessary to target psychosocial factors that may activate or worsen symptoms in PBD, and to address associated academic, interpersonal, and functional impairment.